Back to Byzance: querelles byzantines over NASH and fibrosis

We enter an era when NASH is becoming a main cause of liver mortality and morbidity: a main cause of cirrhosis, a main cause of decompensated cirrhosis and end-stage liver disease [1], a main cause of primary liver cancer[2,3], a main cause of listing for liver transplantation [1,4]. It took a long time for this to be accepted ([5 –8]) although there was precedent with hepatitis C: as surprising as it may seem nowadays, back one to two decades ago, arguments have been raised against HCV infection as a significant cause of serious liver disease [9–11].

Source: Journal of Hepatology - September 28, 2017 Category: Gastroenterology Authors: Vlad Ratziu Source Type: research